FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964202280> ?p ?o ?g. }

• W2964202280 endingPage "201" @default.
• W2964202280 startingPage "193" @default.
• W2964202280 abstract "Abstract Background Multidrug-resistant (MDR) Acinetobacter baumannii infections have high mortality rates and few treatment options. Synergistic drug combinations may improve clinical outcome and reduce further emergence of resistance in MDR pathogens. Here we show an unexpected potent synergy of two translation inhibitors against the pathogen: commonly prescribed macrolide antibiotic azithromycin (AZM), widely ignored as a treatment alternative for invasive Gram-negative pathogens, and minocycline, among the current standard-of-care agents used for A. baumannii. Methods Media-dependent activities of AZM and MIN were evaluated in minimum inhibitory concentration assays and kinetic killing curves, alone or in combination, both in standard bacteriologic media (cation-adjusted Mueller-Hinton Broth) and more physiologic tissue culture media (RPMI), with variations of bicarbonate as a physiologic buffer. Synergy was calculated by fractional inhibitory concentration index (FICI). Therapeutic benefit of combining AZM and MIN was tested in a murine model of A. baumannii pneumonia. AZM + MIN synergism was probed mechanistically by bacterial cytological profiling (BCP), a quantitative fluorescence microscopy technique that identifies disrupted bacterial cellular pathways on a single cell level, and real-time kinetic measurement of translation inhibition via quantitative luminescence. AZM + MIN synergism was further evaluated vs. other contemporary high priority MDR bacterial pathogens. Findings Although two translation inhibitors are not expected to synergize, each drug complemented kinetic deficiencies of the other, speeding the initiation and extending the duration of translation inhibition as verified by FICI, BCP and kinetic luminescence markers. In an MDR A. baumannii pneumonia model, AZM + MIN combination therapy decreased lung bacterial burden and enhanced survival rates. Synergy between AZM and MIN was also detected vs. MDR strains of Gram-negative Klebsiella pneumoniae and Pseudomonas aeruginosa, and the leading Gram-positive pathogen methicillin-resistant Staphylococcus aureus. Interpretation As both agents are FDA approved with excellent safety profiles, clinical investigation of AZM and MIN combination regimens may immediately be contemplated for optimal treatment of A. baumannii and other MDR bacterial infections in humans. Fund National Institutes of Health U01 AI124326 (JP, GS, VN) and U54 HD090259 (GS, VN). IC was supported by the UCSD Research Training Program for Veterinarians T32 OD017863." @default.
• W2964202280 created "2019-07-30" @default.
• W2964202280 creator A5007730170 @default.
• W2964202280 creator A5007767031 @default.
• W2964202280 creator A5017445754 @default.
• W2964202280 creator A5023501690 @default.
• W2964202280 creator A5024921031 @default.
• W2964202280 creator A5042162895 @default.
• W2964202280 creator A5044814780 @default.
• W2964202280 creator A5067852918 @default.
• W2964202280 date "2019-08-01" @default.
• W2964202280 modified "2023-10-17" @default.
• W2964202280 title "Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens" @default.
• W2964202280 cites W1967003483 @default.
• W2964202280 cites W1969383148 @default.
• W2964202280 cites W1976894397 @default.
• W2964202280 cites W1993658572 @default.
• W2964202280 cites W2002295643 @default.
• W2964202280 cites W2005719553 @default.
• W2964202280 cites W2006881751 @default.
• W2964202280 cites W2016562927 @default.
• W2964202280 cites W2016624659 @default.
• W2964202280 cites W2035164474 @default.
• W2964202280 cites W2054807444 @default.
• W2964202280 cites W2057964213 @default.
• W2964202280 cites W2060724686 @default.
• W2964202280 cites W2080181642 @default.
• W2964202280 cites W2082981604 @default.
• W2964202280 cites W2101273146 @default.
• W2964202280 cites W2102749349 @default.
• W2964202280 cites W2104455358 @default.
• W2964202280 cites W2106521502 @default.
• W2964202280 cites W2110991941 @default.
• W2964202280 cites W2115076532 @default.
• W2964202280 cites W2139379138 @default.
• W2964202280 cites W2140595402 @default.
• W2964202280 cites W2143401494 @default.
• W2964202280 cites W2153579889 @default.
• W2964202280 cites W2160653375 @default.
• W2964202280 cites W2164190593 @default.
• W2964202280 cites W2167293860 @default.
• W2964202280 cites W2171338914 @default.
• W2964202280 cites W2344209271 @default.
• W2964202280 cites W2419535666 @default.
• W2964202280 cites W2522676808 @default.
• W2964202280 cites W2601453096 @default.
• W2964202280 cites W2618823124 @default.
• W2964202280 cites W2637550166 @default.
• W2964202280 cites W2779359811 @default.
• W2964202280 doi "https://doi.org/10.1016/j.ebiom.2019.07.041" @default.
• W2964202280 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6711115" @default.
• W2964202280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31353294" @default.
• W2964202280 hasPublicationYear "2019" @default.
• W2964202280 type Work @default.
• W2964202280 sameAs 2964202280 @default.
• W2964202280 citedByCount "30" @default.
• W2964202280 countsByYear W29642022802019 @default.
• W2964202280 countsByYear W29642022802020 @default.
• W2964202280 countsByYear W29642022802021 @default.
• W2964202280 countsByYear W29642022802022 @default.
• W2964202280 countsByYear W29642022802023 @default.
• W2964202280 crossrefType "journal-article" @default.
• W2964202280 hasAuthorship W2964202280A5007730170 @default.
• W2964202280 hasAuthorship W2964202280A5007767031 @default.
• W2964202280 hasAuthorship W2964202280A5017445754 @default.
• W2964202280 hasAuthorship W2964202280A5023501690 @default.
• W2964202280 hasAuthorship W2964202280A5024921031 @default.
• W2964202280 hasAuthorship W2964202280A5042162895 @default.
• W2964202280 hasAuthorship W2964202280A5044814780 @default.
• W2964202280 hasAuthorship W2964202280A5067852918 @default.
• W2964202280 hasBestOaLocation W29642022801 @default.
• W2964202280 hasConcept C104317684 @default.
• W2964202280 hasConcept C105580179 @default.
• W2964202280 hasConcept C133936738 @default.
• W2964202280 hasConcept C149364088 @default.
• W2964202280 hasConcept C159047783 @default.
• W2964202280 hasConcept C2776315533 @default.
• W2964202280 hasConcept C2777637488 @default.
• W2964202280 hasConcept C2778523567 @default.
• W2964202280 hasConcept C2993175405 @default.
• W2964202280 hasConcept C501593827 @default.
• W2964202280 hasConcept C523546767 @default.
• W2964202280 hasConcept C54355233 @default.
• W2964202280 hasConcept C71924100 @default.
• W2964202280 hasConcept C86803240 @default.
• W2964202280 hasConcept C89423630 @default.
• W2964202280 hasConceptScore W2964202280C104317684 @default.
• W2964202280 hasConceptScore W2964202280C105580179 @default.
• W2964202280 hasConceptScore W2964202280C133936738 @default.
• W2964202280 hasConceptScore W2964202280C149364088 @default.
• W2964202280 hasConceptScore W2964202280C159047783 @default.
• W2964202280 hasConceptScore W2964202280C2776315533 @default.
• W2964202280 hasConceptScore W2964202280C2777637488 @default.
• W2964202280 hasConceptScore W2964202280C2778523567 @default.
• W2964202280 hasConceptScore W2964202280C2993175405 @default.
• W2964202280 hasConceptScore W2964202280C501593827 @default.
• W2964202280 hasConceptScore W2964202280C523546767 @default.
• W2964202280 hasConceptScore W2964202280C54355233 @default.

• next